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Living	with	Fragile	X	Syndrome:	Occupa:ons	as	an	Outcome	Measure	in	a	Clinical	Trial	
Ana	Baldinger	OTS,	Theresa	Chase	OTS,	Ty	Duong	OTS,	Kaylee	Gothelf	OTS,		Laura	Greiss	Hess	PhD,	OTR/L	(Faculty	Advisor)	
	
Dominican	University	of	California,	Department	of	Occupa:onal	Therapy	
Fragile	X	syndrome	(FXS)	is	the	most	common	inherited	cause	of	
intellectual	and	developmental	disability	&	single	gene	cause	of	au:sm	
spectrum	disorder	(Na:onal	Fragile	X	Founda:on,	2017)	
	
•  Previous	studies	used	quan:ta:ve	methods	(parent	checklists	and	
standardized	assessments)		
Ø Outcome	measures	oWen	do	not	reflect	daily	occupa:ons	and	
lack	sensi:vity	for	FXS	(Berry-Kravis	et	al.,	2012)	
	
Occupa7ons	are	ac:vi:es	that	provide	meaning	and	a	sense	of	
purpose	in	daily	life	
	
Sociocultural	theory	-	Learning	is	not	constrained	by	biology.	Learning	
is	social	and	cultural.	Occupa7ons	happen	in	sociocultural	contexts	
	
	
	
	
	
	
Qualita7ve	research	-	interview	methods	to	provide	voice	and	
context	of	lived	experiences	of	families	&	children	with	FXS	
	
Par7cipants:	Families	of	children	with		full-muta4on	FXS,	ages	2-6		
•  Original	study	evaluated	the	effects	of	low-dose	sertraline	(ZoloW®)	
on	language	development,	anxiety,	and	addi:onal	behavioral	
symptoms	(Hess	et	al.,	2016)	
Data:	25	audio	interviews	of	FXS	families	obtained	from	the	U.C.	Davis	
MIND	Ins:tute.	Interviews	were	conducted	at	6	months	post	tes:ng.	
•  Interviews	transcribed	verba:m	using	Express	Scribe	soWware	
Analysis:	Interviews	coded	(researchers	blind	to	group	assignment).	
Data	analyzed	using	Constant	Comparison	Method	with	Dedoose	
soWware		
•  3	interviews	coded	with	100%	consensus	by	4	researchers	
•  17	interviews	coded	with	100%	consensus	by	2	researchers	
	
•  Categories	&	Codes	(improved,	not	improved	or	no	change)	
Ø Behaviors,	anxiety,	sensory	processing,	communica5on,	
strategies,	play,	func5onal/ADLs,	social	par5cipa5on		
METHODOLOGY	
•  Children	in	the	sertraline	group	showed	greater	improvements	than	
the	placebo	group	in	6	areas	of	daily	func4oning:	
•  Therapeu4c	strategies	were	used	by	families	in	both	groups,	but	
more	prominently	in	the	placebo	group	(with	the	excep5on	of	
sensory)	
	
	
	
	
•  Analysis	of	semi-structured	interviews	revealed	differences	between	
the	placebo	and	sertraline	groups	in	occupa5onal	performance	
outcomes	
Ø  Interviews	allowed	for	family	voice,	context	and	rich	descrip5on	
of	daily	experiences	of	families	with	FXS.				
	
•  Outcome	measures	in	clinical	trials	inclusive	of	sociocultural	and	
occupa4onal	factors	may	gather	a	broader	scope	of	daily	life	
improvements	vs.	what	can	be	measured	on	quan:ta:ve	
instruments	(e.g.	mostly	performance	skills)	alone.	
	
•  OTs	have	a	role	to	play	in	clinical	trials	→	provide	holis7c	approach	
&	occupa7on-based	lens	to	beeer	understand	how	interven4ons	
impact	occupa4onal	engagement	for	a	child	with	FXS	
•  Future	Direc7ons:	
Ø  Inves:gate	how	various	therapeu:c	strategies	can	help	support	
children	when	taking	medica:ons		
Ø  Incorporate	interviews	as	outcome	measures	with	families	to	
add	depth,	context	&	addi4onal	sensi4vity	for	the	FXS	
popula:on	
RESEARCH	QUESTION	
Can	semi-structured	parent	interviews	be	used	to	determine	difference	
in	improved	daily	func:oning	between	placebo	and	treatment	groups	
when	studying	children	with	FXS	during	a	clinical	medica:on	trial?	
RESULTS	
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DISCUSSION	&	OT	IMPLICATIONS	
Ø  Have	you	no7ced	any	changes	related	to	anxiety,	communica7on,	behavior,	sensory?		
Ø  How	has	this	impacted	you	as	a	family?	
 
Communica7on	 Behavior	
Sensory	
The	other	thing	is	they	feel	his	language	is	
improved.	It’s	not	showing	so	much	on	the	
tes:ng…he	is	actually	doing	a	lot.		
 
So	his	behavior	has	improved	in	the	sense	that	he	
used	to	throw	a	lot	of	tantrums.	Whenever	he	got	
frustrated	he	would	throw	himself	on	the	floor	and	
scoot	backwards	and	his	head	would	hit	the	floor.	
And	his	interac:ons	with	his	peers	are	beeer.	
That	was	one	of	his	goals.	And	his	aid	that	goes	to	
school	with	him	said	that	he'll	ini:ate	interac:ons	
with	them	and	try	to	communicate	with	them.	
He	would	chew	on	a	shirt	all	the	:me,	always	a	
shirt	in	his	mouth.	He	did	that	briefly	when	he	
started	back	to	school	this	fall,	and	I	haven't	seen	
him	do	it	in	weeks.			
Researcher	
Social	par7cipa7on	
&	
Educa7on	
She’s	got	a	wiggle	cushion.	She	needs	to	take	a	
few	breaks	and	even	if	it	just	helps	her	feel	more	
calm.		
If	we	don’t	understand	what	he	is	saying,	show	me	
a	picture,	show	me	what	you	are	talking	about	and	
he	will	show	you.	
Technology	
Communica7on	 Sensory	
In	order	to	calm	her	down,	I’d	sit	her	in	a	chair	and	
she	watched	a	YouTube	video	on	my	computer	
with	a	couple	of	super	simple	songs.		
I	can	give	her	‘you	need	to	go	do	this	and	then	you	can	
have	this’.	She	understands	if	I	do	something,	then	this	
will	happen.	She	understands.	
Behavior	Mod.	
Ø Zone	of	proximal	development	(ZPD)	
=	the	op:mal	level	for	a	child	to	
explore	and	learn,	with	addi:onal	
outside	reinforcement	&	social	
support	(Vygotsky,	1930)	
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